Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Effect of national HIV testing recommendations and local interventions on HIV testing practices in a Swiss university hospital: a retrospective analysis between 2012 and 2015.

Lazzarino T, Martenet S, Mamin R, Du Pasquier RA, Peters S, Perreau M, Muller O, Hugli O, Cavassini M, Darling KEA.

BMJ Open. 2018 Oct 3;8(10):e021203. doi: 10.1136/bmjopen-2017-021203.

2.

Rivastigmine decreases brain damage in HIV patients with mild cognitive deficits.

Perrotta G, Bonnier G, Meskaldji DE, Romascano D, Aydarkhanov R, Daducci A, Simioni S, Cavassini M, Metral M, Lazeyras F, Meuli R, Krueger G, Du Pasquier RA, Granziera C.

Ann Clin Transl Neurol. 2017 Nov 7;4(12):915-920. doi: 10.1002/acn3.493. eCollection 2017 Dec.

3.

[Neurology].

Maulucci F, Benninger D, Démonet JF, Du Pasquier RA, Hirt L, Hottinger A, Kuntzer T, Michel P, Nater B, Novy J, Rossetti AO, Schluep M, Vingerhoets FJG.

Rev Med Suisse. 2017 Jan 11;13(544-545):79-83. Review. French.

PMID:
28703543
4.

Clinical Reasoning: An 82-year-old woman with dissociated aphasia followed by amnesia.

Eskioglou E, Du Pasquier RA, Rossetti AO, Sokolov AA.

Neurology. 2016 Aug 30;87(9):e91-6. doi: 10.1212/WNL.0000000000003047. No abstract available.

PMID:
27572435
5.

Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.

Mathias A, Perriard G, Canales M, Soneson C, Delorenzi M, Schluep M, Du Pasquier RA.

Mult Scler. 2017 May;23(6):802-809. doi: 10.1177/1352458516664210. Epub 2016 Aug 8.

PMID:
27503907
6.

[Neurology].

Sokolov AA, Rossetti AO, Michel P, Benninger D, Nater B, Wider C, Hirt L, Kuntzer T, Démonet JF, Du Pasquier RA, Vingerhoets F.

Rev Med Suisse. 2016 Jan 13;12(500):62, 64-6. French.

PMID:
26946707
7.

PML risk stratification using anti-JCV antibody index and L-selectin.

Schwab N, Schneider-Hohendorf T, Pignolet B, Spadaro M, Görlich D, Meinl I, Windhagen S, Tackenberg B, Breuer J, Cantó E, Kümpfel T, Hohlfeld R, Siffrin V, Luessi F, Posevitz-Fejfár A, Montalban X, Meuth SG, Zipp F, Gold R, Du Pasquier RA, Kleinschnitz C, Jacobi A, Comabella M, Bertolotto A, Brassat D, Wiendl H.

Mult Scler. 2016 Jul;22(8):1048-60. doi: 10.1177/1352458515607651. Epub 2015 Oct 2.

PMID:
26432858
8.

Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.

Perriard G, Mathias A, Enz L, Canales M, Schluep M, Gentner M, Schaeren-Wiemers N, Du Pasquier RA.

J Neuroinflammation. 2015 Jun 16;12:119. doi: 10.1186/s12974-015-0335-3.

9.

[News in neurology 2014].

Tsetsou S, Rossetti AO, Michel P, Hirt L, Wider C, Benninger D, Kuntzer T, Nater B, Démonet JF, Schluep M, Du Pasquier RA, Vingerhoets F.

Rev Med Suisse. 2015 Jan 14;11(456-457):91-6. French.

PMID:
25799659
10.

Posterior spinal cord infarctions due to neurosyphilis.

Bill O, Du Pasquier RA, Michel P.

Neurol Clin Pract. 2014 Dec;4(6):538-540. doi: 10.1212/CPJ.0000000000000053. No abstract available.

11.

Immune system's role in viral encephalitis.

Spatola M, Du Pasquier RA.

Rev Neurol (Paris). 2014 Oct;170(10):577-83. doi: 10.1016/j.neurol.2014.07.005. Epub 2014 Sep 2.

PMID:
25189678
12.

Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.

Du Pasquier RA, Pinschewer DD, Merkler D.

CNS Drugs. 2014 Jun;28(6):535-58. doi: 10.1007/s40263-014-0160-8. Review.

13.

[News in neurology 2013].

Spatola M, Rossetti AO, Michel P, Kuntzer T, Benninger D, Nater B, Démonet JF, Schluep M, Du Pasquier RA, Vingerhoets F.

Rev Med Suisse. 2014 Jan 15;10(412-413):78-81. Review. French.

PMID:
24558905
14.

Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients.

Jilek S, Mathias A, Canales M, Lysandropoulos A, Pantaleo G, Schluep M, Du Pasquier RA.

Mult Scler. 2014 Jun;20(7):837-42. doi: 10.1177/1352458513513208. Epub 2013 Nov 20.

PMID:
24258149
15.

Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field.

Granziera C, Daducci A, Simioni S, Cavassini M, Roche A, Meskaldji D, Kober T, Metral M, Calmy A, Helms G, Hirschel B, Lazeyras F, Meuli R, Krueger G, Du Pasquier RA.

PLoS One. 2013 Sep 10;8(9):e72547. doi: 10.1371/journal.pone.0072547. eCollection 2013.

16.

Author Response.

Du Pasquier RA, Canales M, Schluep M.

Neurology. 2013 Jul 2;81(1):98. No abstract available.

PMID:
23980272
17.

[New treatment options in multiple sclerosis and their complications].

Schluep M, Lalive PH, Du Pasquier RA.

Rev Med Suisse. 2013 May 1;9(384):940-3. French.

PMID:
23717904
18.

[Dysimmune neuromuscular disorders: diagnostic challenges and new ways of management].

Lalive PH, Du Pasquier RA, Chizzolini C, Kuntzer T.

Rev Med Suisse. 2013 May 1;9(384):934-9. Review. French.

PMID:
23717903
19.

[Anti-neuronal antibodies: a rapidly developing field].

Zekeridou A, Rossetti AO, Hottinger AF, Du Pasquier RA.

Rev Med Suisse. 2013 May 1;9(384):909-14. Review. French.

PMID:
23717899
20.

[Head inflammation].

Du Pasquier RA, Lalive PH.

Rev Med Suisse. 2013 May 1;9(384):907. French. No abstract available.

PMID:
23717898
21.

A light in the cognitive fog?

Cavassini M, Du Pasquier RA.

Antivir Ther. 2013;18(2):149-51. doi: 10.3851/IMP2561. Epub 2013 Mar 13.

PMID:
23486740
22.

Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study.

Simioni S, Cavassini M, Annoni JM, Métral M, Iglesias K, Rimbault Abraham A, Jilek S, Calmy A, Müller H, Fayet-Mello A, Giacobini E, Hirschel B, Du Pasquier RA.

Neurology. 2013 Feb 5;80(6):553-60. doi: 10.1212/WNL.0b013e3182815497. Epub 2013 Jan 23.

PMID:
23345635
23.

Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.

Simioni S, Schluep M, Bault N, Coricelli G, Kleeberg J, Du Pasquier RA, Gschwind M, Vuilleumier P, Annoni JM.

PLoS One. 2012;7(12):e50718. doi: 10.1371/journal.pone.0050718. Epub 2012 Dec 5.

24.

Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?

Antoniol C, Jilek S, Schluep M, Mercier N, Canales M, Le Goff G, Campiche C, Pantaleo G, Du Pasquier RA.

Neurology. 2012 Dec 4;79(23):2258-64. doi: 10.1212/WNL.0b013e3182768983. Epub 2012 Nov 21.

PMID:
23175722
25.

Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy.

Du Pasquier RA, Jilek S, Kalubi M, Yerly S, Fux CA, Gutmann C, Cusini A, Günthard HF, Cavassini M, Vernazza PL; Swiss HIV Cohort Study.

AIDS. 2013 Jan 14;27(2):203-10. doi: 10.1097/QAD.0b013e32835a9a4a.

PMID:
23032410
26.

HIV testing practices by clinical service before and after revised testing guidelines in a Swiss University Hospital.

Darling KE, Hugli O, Mamin R, Cellerai C, Martenet S, Berney A, Peters S, Du Pasquier RA, Bodenmann P, Cavassini M.

PLoS One. 2012;7(6):e39299. doi: 10.1371/journal.pone.0039299. Epub 2012 Jun 28.

27.

MOBP-specific cellular immune responses are weaker than MOG-specific cellular immune responses in patients with multiple sclerosis and healthy subjects.

Jilek S, Schluep M, Pantaleo G, Du Pasquier RA.

Neurol Sci. 2013 Apr;34(4):539-43. doi: 10.1007/s10072-012-1144-4. Epub 2012 Jun 30.

PMID:
22752855
28.

Progressive multifocal leukoencephalopathy in a patient with transitory lymphopenia.

Chabwine JN, Lhermitte B, Da Silva MO, Buss G, Maeder P, Du Pasquier RA.

Neurology. 2012 Jun 12;78(24):2000-2. doi: 10.1212/WNL.0b013e318259e210. Epub 2012 May 30. No abstract available.

PMID:
22649215
29.

Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Ludigs K, Parfenov V, Du Pasquier RA, Guarda G.

Cell Mol Life Sci. 2012 Oct;69(20):3395-418. doi: 10.1007/s00018-012-0989-2. Epub 2012 Apr 24. Review.

PMID:
22527721
30.

HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.

Jilek S, Schluep M, Harari A, Canales M, Lysandropoulos A, Zekeridou A, Pantaleo G, Du Pasquier RA.

J Immunol. 2012 May 1;188(9):4671-80. doi: 10.4049/jimmunol.1103100. Epub 2012 Mar 28.

31.

[Neurology].

Chabwine JN, Rossetti AR, Hirt L, Kuntzer T, Schluep M, Michel P, Démonet JF, du Pasquier RA, Vingerhoets FG.

Rev Med Suisse. 2012 Jan 11;8(323):46-50. French.

PMID:
22303740
32.

Fatal PML associated with efalizumab therapy: insights into integrin αLβ2 in JC virus control.

Schwab N, Ulzheimer JC, Fox RJ, Schneider-Hohendorf T, Kieseier BC, Monoranu CM, Staugaitis SM, Welch W, Jilek S, Du Pasquier RA, Brück W, Toyka KV, Ransohoff RM, Wiendl H.

Neurology. 2012 Feb 14;78(7):458-67; discussion 465. doi: 10.1212/WNL.0b013e3182478d4b. Epub 2012 Feb 1.

33.

Immunological and clinical consequences of treating a patient with natalizumab.

Schwab N, Höhn KG, Schneider-Hohendorf T, Metz I, Stenner MP, Jilek S, Du Pasquier RA, Gold R, Meuth SG, Ransohoff RM, Brück W, Wiendl H.

Mult Scler. 2012 Mar;18(3):335-44. doi: 10.1177/1352458511421919. Epub 2011 Sep 9.

PMID:
21908480
34.

Type I interferon inhibits interleukin-1 production and inflammasome activation.

Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Förster I, Farlik M, Decker T, Du Pasquier RA, Romero P, Tschopp J.

Immunity. 2011 Feb 25;34(2):213-23. doi: 10.1016/j.immuni.2011.02.006.

35.

Rituximab is successful in an HIV-positive patient with MuSK myasthenia gravis.

Kuntzer T, Carota A, Novy J, Cavassini M, Du Pasquier RA.

Neurology. 2011 Feb 22;76(8):757-8. doi: 10.1212/WNL.0b013e31820d6290. No abstract available.

PMID:
21339503
36.

[Therapeutic advances in neurology].

Siclari F, du Pasquier RA, Schluep M, Michel P, Hirt L, Kuntzer T, Rossetti AO, Ghika J, Nater B, Vingerhoets FJ.

Rev Med Suisse. 2011 Jan 12;7(277):50-6. Review. French.

PMID:
21309175
37.

Vitamin D has a direct immunomodulatory effect on CD8+ T cells of patients with early multiple sclerosis and healthy control subjects.

Lysandropoulos AP, Jaquiéry E, Jilek S, Pantaleo G, Schluep M, Du Pasquier RA.

J Neuroimmunol. 2011 Apr;233(1-2):240-4. doi: 10.1016/j.jneuroim.2010.11.008. Epub 2010 Dec 24.

PMID:
21186064
38.

EFNS guidelines on diagnosis and management of neuromyelitis optica.

Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B.

Eur J Neurol. 2010 Aug;17(8):1019-32. doi: 10.1111/j.1468-1331.2010.03066.x. Epub 2010 Jun 7. Review.

PMID:
20528913
39.

Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: a pilot study.

Jaquiéry E, Jilek S, Schluep M, Le Goff G, Garcia M, Pantaleo G, Du Pasquier RA.

J Neuroimmunol. 2010 Aug 25;225(1-2):167-70. doi: 10.1016/j.jneuroim.2010.04.011. Epub 2010 May 15.

PMID:
20471696
40.

Demyelination as a complication of new immunomodulatory treatments.

Lysandropoulos AP, Du Pasquier RA.

Curr Opin Neurol. 2010 Jun;23(3):226-33. doi: 10.1097/WCO.0b013e3283398c96. Review.

PMID:
20442571
41.

A promenade along the stream of demyelination.

Du Pasquier RA.

Curr Opin Neurol. 2010 Jun;23(3):203-4. doi: 10.1097/WCO.0b013e328339d15d. No abstract available.

PMID:
20442569
42.

Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.

Cvetkovic-Lopes V, Bayer L, Dorsaz S, Maret S, Pradervand S, Dauvilliers Y, Lecendreux M, Lammers GJ, Donjacour CE, Du Pasquier RA, Pfister C, Petit B, Hor H, Mühlethaler M, Tafti M.

J Clin Invest. 2010 Mar;120(3):713-9. doi: 10.1172/JCI41366. Epub 2010 Feb 15.

43.

Immune responses to JC virus in patients with multiple sclerosis treated with natalizumab: a cross-sectional and longitudinal study.

Jilek S, Jaquiéry E, Hirsch HH, Lysandropoulos A, Canales M, Guignard L, Schluep M, Pantaleo G, Du Pasquier RA.

Lancet Neurol. 2010 Mar;9(3):264-72. doi: 10.1016/S1474-4422(10)70006-5. Epub 2010 Jan 29.

PMID:
20117055
44.

Intrathecal immune responses to EBV in early MS.

Jaquiéry E, Jilek S, Schluep M, Meylan P, Lysandropoulos A, Pantaleo G, Du Pasquier RA.

Eur J Immunol. 2010 Mar;40(3):878-87. doi: 10.1002/eji.200939761. Erratum in: Eur J Immunol. 2011 May;41(5):1501.

45.

Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.

Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, Schiffer V, Calmy A, Chave JP, Giacobini E, Hirschel B, Du Pasquier RA.

AIDS. 2010 Jun 1;24(9):1243-50. doi: 10.1097/QAD.0b013e3283354a7b.

PMID:
19996937
46.

[Autoantibodies in neurological diseases: clinical implications].

Lalive PH, Chofflon M, Du Pasquier RA, Burkhard PR.

Rev Med Suisse. 2009 Apr 29;5(201):942-4, 946-8, 950. French.

PMID:
19476056
47.

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.

Khanna N, Wolbers M, Mueller NJ, Garzoni C, Du Pasquier RA, Fux CA, Vernazza P, Bernasconi E, Viscidi R, Battegay M, Hirsch HH; Swiss HIV Cohort Study.

J Virol. 2009 May;83(9):4404-11. doi: 10.1128/JVI.02657-08. Epub 2009 Feb 11.

48.

Progressive decline of decision-making performances during multiple sclerosis.

Simioni S, Ruffieux C, Kleeberg J, Bruggimann L, du Pasquier RA, Annoni JM, Schluep M.

J Int Neuropsychol Soc. 2009 Mar;15(2):291-5. doi: 10.1017/S1355617709090262. Epub 2009 Feb 10.

PMID:
19203433
49.

[Neuropsychiatry].

Burkhard PR, Vingerhoets FJ, Landis T, Du Pasquier RA.

Rev Med Suisse. 2008 May 7;4(156):1131-2. French. No abstract available.

PMID:
18630166
50.

Inaugural description of Cogan syndrome in an HIV-infected person.

Kleeberg J, Maire R, Chave JP, Pournaras JA, Guex-Crosier Y, Du Pasquier RA.

J Neurol. 2008 Sep;255(9):1427-8. doi: 10.1007/s00415-008-0933-4. Epub 2008 Jun 30. No abstract available.

PMID:
18575918

Supplemental Content

Loading ...
Support Center